Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,000 | 527 | 86.7% |
| Education | $1,222 | 5 | 13.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,219 | 77 | $0 (2024) |
| Sioux Surgical Inc | $1,200 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,044 | 52 | $0 (2024) |
| Lilly USA, LLC | $777.45 | 53 | $0 (2024) |
| GlaxoSmithKline, LLC. | $535.70 | 35 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $493.90 | 28 | $0 (2024) |
| PFIZER INC. | $482.28 | 46 | $0 (2024) |
| ABBVIE INC. | $454.90 | 32 | $0 (2024) |
| Astellas Pharma US Inc | $422.86 | 28 | $0 (2024) |
| Abbott Laboratories | $337.36 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,242 | 76 | Bayer Healthcare Pharmaceuticals Inc. ($182.62) |
| 2023 | $1,383 | 82 | Boehringer Ingelheim Pharmaceuticals, Inc. ($201.51) |
| 2022 | $1,099 | 65 | Boehringer Ingelheim Pharmaceuticals, Inc. ($266.11) |
| 2021 | $1,934 | 51 | Sioux Surgical Inc ($1,200) |
| 2020 | $719.40 | 48 | GlaxoSmithKline, LLC. ($206.28) |
| 2019 | $695.92 | 44 | AstraZeneca Pharmaceuticals LP ($249.68) |
| 2018 | $972.31 | 79 | AstraZeneca Pharmaceuticals LP ($219.97) |
| 2017 | $1,176 | 87 | AstraZeneca Pharmaceuticals LP ($263.97) |
All Payment Transactions
532 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Cardio-renal | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Cardio-renal | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: PAIN | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: UROLOGY | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: VACCINES | ||||||
| 10/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: VACCINES | ||||||
| 10/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $29.50 | General |
| Category: Cardiovascular | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: OUD | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Cardio-renal | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.18 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 169 | 379 | $46,780 | $24,096 |
| 2022 | 4 | 172 | 328 | $43,155 | $20,087 |
| 2021 | 5 | 211 | 400 | $52,741 | $25,071 |
| 2020 | 7 | 330 | 579 | $74,843 | $37,714 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 73 | 269 | $29,456 | $15,979 | 54.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 53 | $10,943 | $4,672 | 42.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 35 | 43 | $4,702 | $2,470 | 52.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $1,679 | $976.50 | 58.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 203 | $22,229 | $10,720 | 48.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 51 | 61 | $12,595 | $5,442 | 43.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 42 | 50 | $5,468 | $2,677 | 49.0% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 13 | 14 | $2,865 | $1,248 | 43.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 69 | 234 | $25,623 | $12,560 | 49.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 51 | 57 | $11,769 | $5,235 | 44.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 48 | 61 | $6,670 | $3,406 | 51.1% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 31 | 36 | $7,367 | $3,189 | 43.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 12 | 12 | $1,312 | $680.88 | 51.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 79 | 289 | $31,598 | $16,563 | 52.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 69 | 76 | $15,692 | $7,615 | 48.5% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 52 | 56 | $11,459 | $5,121 | 44.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 70 | 79 | $8,639 | $4,584 | 53.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 28 | 31 | $3,390 | $1,714 | 50.6% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2020 | 14 | 24 | $2,640 | $1,412 | 53.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 18 | 24 | $1,426 | $704.14 | 49.4% |
About Dr. Joshua Bowers, M.D
Dr. Joshua Bowers, M.D is a Family Medicine healthcare provider based in Canton, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1194947002.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Bowers, M.D has received a total of $9,222 in payments from pharmaceutical and medical device companies, with $1,242 received in 2024. These payments were reported across 532 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($8,000).
As a Medicare-enrolled provider, Bowers has provided services to 882 Medicare beneficiaries, totaling 1,686 services with total Medicare billing of $106,968. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Canton, IL
- Active Since 05/02/2007
- Last Updated 04/14/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1194947002
Products in Payments
- JARDIANCE (Drug) $850.25
- FARXIGA (Drug) $782.43
- Kerendia (Drug) $479.97
- TRADJENTA (Drug) $447.14
- TRELEGY ELLIPTA (Drug) $406.19
- VRAYLAR (Drug) $338.89
- ELIQUIS (Drug) $247.79
- TRULICITY (Drug) $208.26
- MOUNJARO (Drug) $204.34
- MYRBETRIQ (Drug) $186.80
- XARELTO (Drug) $186.64
- FREESTYLE LIBRE 2 (Device) $174.84
- Myrbetriq (Drug) $156.07
- LEQVIO (Drug) $150.87
- JANUVIA (Drug) $136.15
- BEVESPI AEROSPHERE (Drug) $133.09
- ENTRESTO (Drug) $128.36
- Ozempic (Drug) $105.67
- CHANTIX (Drug) $103.93
- ANORO ELLIPTA (Drug) $102.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Canton
Diana Brewster, Do, DO
Family Medicine — Payments: $19,624
Dr. Benjamin Swisher, M.d, M.D
Family Medicine — Payments: $17,371
Amy Hubert, M.d, M.D
Family Medicine — Payments: $15,764
Dr. Tammy Eisentrout, D.o, D.O
Family Medicine — Payments: $12,104
Jeffrey Stone, Md, MD
Family Medicine — Payments: $11,005
Kerwin Joel Lupisan, Md, MD
Family Medicine — Payments: $10,871